Skip to main content

Table 4 CMR findings divided by LGE status

From: T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides

  LGE negative (n = 21) LGE positive (n = 16) p
LV-EF (%) 69 ± 7 59 ± 12 0.01
LV-EDV (ml) 117 ± 40 128 ± 44 0.37
LV-ESV (ml) 38 ± 21 56 ± 38 0.06
LV-SV 79 ± 22 72 ± 11 0.43
LV-EDD 47 ± 6 49 ± 4 0.09
LA (cm2) 21 ± 5 20 ± 4 0.54
IVS (mm) 10 ± 2 11 ± 2 0.56
PA (mm) 25 ± 4 25 ± 2 0.75
LV mass (g) 90 ± 25 90 ± 24 0.93
LGE per patient - 16 (100%)  
epicardial - 6 (37%)  
intramural - 6 (37%)  
transmural - -  
subendocardial - 4 (25%)  
% LV mass - 6.8 ± 5  
Native T1 (ms) 1002 (970–1025) 982 (957–998) 0.10
Post-contrast T1 (ms) 501 (478–542) 477 (429–497) 0.04
ECV (%) 27 (25–28) 28 (26–32) 0.13
T2 (ms) 51 (50–55) 54 (52–56) 0.14
  1. All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume